Here is how Axcelis Technologies (ACLS) and F5 Networks (FFIV) have performed compared to their sector so far this year.
Axcelis partners with GE Aerospace on SiC superjunction power devices, leveraging its Purion XEmax implanter to advance extreme-condition technologies.
Axcelis Technologies (ACLS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Axcelis (ACLS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy James G. Coogan - Executive VP & CFO Russell J.
Axcelis Technologies (ACLS) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $1.55 per share a year ago.
Despite a broader industry downturn that saw its revenues decline sharply, Axcelis Technologies, Inc. is expanding its gross, operating, and free cash flow margins while maintaining a robust balance sheet. Recent data indicates that the semiconductor industry is heading to a cyclical rebound later this year, potentially setting Axcelis up for a return to revenue growth. Axcelis' ion implanters are specialized in wide band-gap materials, allowing it to capitalize on the growing adoption for SiC and GaN semiconductors.
The Zacks Electronics - Manufacturing Machinery industry participants, such as ENTG, KLIC, and ACLS, are benefiting from strong demand for high-performance computing, advanced packaging and memory.
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $66.89, denoting a -2.32% move from the preceding trading day.
Axcelis Technologies stands to benefit from the semiconductor industry's demand for advanced ion implantation, driven by smaller node geometries and new device architectures. Despite recent cyclical downturns impacting revenue and margins, Axcelis maintains pricing discipline and a resilient service business to buffer volatility. Axcelis' deep specialization in ion implantation gives it a technical edge over broader competitors like Applied Materials, supporting long-term growth.
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $67.93, denoting a -4% move from the preceding trading day.
The latest trading day saw Axcelis Technologies (ACLS) settling at $60.36, representing a -1.85% change from its previous close.